罗欣药业：8月18日将召开2025年第四次临时股东大会

Core Viewpoint - The company, Luoxin Pharmaceutical (002793), announced that it will hold its fourth extraordinary general meeting of shareholders on August 18, 2025, to review a proposal regarding providing guarantees for its controlling subsidiary [1] Group 1 - The extraordinary general meeting is scheduled for August 18, 2025 [1] - The agenda includes a proposal to provide guarantees for a controlling subsidiary [1]